By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics has regained compliance with a Nasdaq rule that its stock meet a minimum $1 share price and will remain listed on the exchange, it announced after the close of the market on Thursday.

The company said that it has received notice from Nasdaq that it will continue being listed on the Nasdaq Capital Market under ticker symbol "ROSGD" through Aug. 3, then revert back to ticker symbol "ROSG" on Aug. 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.